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Abstract
Currently, the prevalence of obesity among children and adolescents and related compli-
cations is considered one of the most important nutritional problems globally. The preva-
lence of childhood obesity in Europe is 10 times higher now than it was in the 1970s. 
Initial assessments of these patients should include taking a careful history (investigating 
comorbidities, family history and potentially modifiable behaviors) and physical exami-
nation. The degree of investigation is dependent on the patient's age and severity of obe-
sity, the findings on history and physical examination and associated familial risk factors. 
Childhood obesity treatment is based on sustained lifestyle changes with family involve-
ment. Management intervention strategies include nutrition, physical activity, behavior 
and lifestyle changes, medication and surgical considerations.
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1. Introduction
Obesity is a chronic disorder of the state of nutrition characterized by an increase in body 
weight due to excessive adipose tissue, which occurs when the calorie intake exceeds the caloric 
needs of a body with low energy expenditure. Obesity is currently a significant public health 
problem, as we have witnessed a dramatic increase in the number of obese and overweight 
children worldwide in the last years. Children’s risk of obesity varies by age and sex groups, 
ethnic/racial groups, socioeconomic status, geographic and rural/urban regions. The obesity eti-
ology is complex, involving genetic, environmental, psycho-socio-cultural, neuroendocrine and 
metabolic factors. Complications of pediatric obesity occur during childhood and adolescence 
and increase the risk for morbidity and mortality in adulthood.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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2. Nosologic framework of obesity in children and adolescent
2.1. Definition
Obesity is an important pediatric public health problem associated with risk of complications 
in childhood and increased morbidity and mortality throughout life. Overweight and obe-
sity predispose people to noncommunicable diseases such as heart disease, diabetes mellitus, 
musculoskeletal and psychological disorders and certain types of cancer [1].
Without intervention, obese infants and young children will likely continue to be obese dur-
ing childhood, adolescence and adulthood [1–3].
The methodological problem of inconsistency between criteria of childhood obesity classifi-
cation is a major obstacle in studying global trends for younger age group. The body mass 
index [BMI: weight (kg)/height (m)2] is the parameter used for the screening of overweight 
and obesity in childhood because it is easy to determine, it tends to correlate well with body 
fat, and it has been widely used in adults to define obesity. It decreases until the period called 
“adiposity rebound” when body fat is at the lowest level (between 3 and 7 years) and after 
then BMI increases again until the adulthood [4, 5].
The child’s BMI must be plotted on nationally recommended BMI—for age charts. The clas-
sification of overweight and obesity varies among guidelines, such as those from Centre 
for Disease Control (CDC), International Obesity Task Force (IOTF) and World Health 
Organization (WHO).
For example, in UK (IOTF BMI values) the cut off points for and are the BMI >91st and >98th 
percentile, respectively.
The definition of overweight and obesity using BMI percentiles in the USA: children aged 
2 years and older with a BMI between the 85th and 95th percentile is overweight, and 
those with a BMI greater than the 95th percentile for a specific age and sex subgroup are 
obese [4–6].
According to WHO, for children aged between 5 and 19 years, overweight is >2 standard 
deviations and obesity is defined as a BMI-for-age >1 standard deviation, above the WHO 
growth reference median [1].
The IOTF BMI values represent standard international references that allow the screening of 
adiposity in children and adolescents worldwide under the same criterion, without variations 
depending on geographic, social and secular trends [5].
2.2. Epidemiological data
Currently, the prevalence of obesity among children and adolescents and related compli-
cations is considered one of the most important nutritional problem globally. The obesity 
epidemic among children is the result of excess energy intake and inadequate energy expen-
diture [2]. The prevalence of childhood overweight and obesity has increased worldwide in 
recent decades, and the numbers of those affected continue to rise at an alarming rate [6].
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In recent years, the epidemiology of overweight and obesity is well described in many 
European countries and the data showed the increasing trends in the prevalence of child-
hood obesity. The current prevalence of childhood obesity is ten times higher than it was in 
the 1970s [5].
The incidence of overweight and obesity increased progressively from infancy through ado-
lescence [5, 6]. High prevalence of obesity in 0- to 6-year-old children is warning signs and risk 
for increased rates of obesity in adolescence and adulthood reported.
North America and some countries in Europe have shown consistent year-on-year increases 
in prevalence of overweight (20–30%) and obesity (5–15%), although recent surveys indi-
cate that the rising trends are easing, with a plateau in prevalence levels shown since 
around 2005 [6].
Children’s risk of obesity varies by age and sex groups, ethnic/racial groups, socioeconomic 
status, geographic and rural/urban regions. The key reason for the variations is due to the 
considerable socioeconomic and lifestyle differences and the differences in differing criteria 
for obesity and overweight definition [4, 7].
Several countries of Southern Europe appear to be showing high prevalence of childhood 
obesity (20–35%) in the Italy, Greece, Malta, Portugal and Spain. The highest levels of over-
weight and obesity were in Southern Italy (30.1 and 33.1% in preschool boys and, respectively, 
girls) and in various regions of Spain (29.4% in both sexes, increasing to 32.6% among chil-
dren aged 7- to 10-year old), followed by Greece (19.1 and 23.6% in boys and, respectively, 
girls) [7–9]. Children and adolescents residing in countries surrounding the Mediterranean 
Sea show the highest rates ranging from 20 to 40%, too [7]. Studies concerning obesity with 
regard to its prevalence in Portugal reported a rate of overweight in children under the age of 
6 years, 13.6% in boys and 20.4% in girls, and, obesity varied between 6.5% in boys and 6.9%, 
respectively, in girls [10]. The very high prevalence of childhood obesity in Mediterranean 
countries could be secondary to lifestyle changes (switching from a healthy Mediterranean 
diet to a fast food type of diet and lower physical activity levels) [7].
In children and adolescents residing the Scandinavian countries and Central Western European 
countries, the prevalence of overweight and obesity is far lower (10–20%). Scandinavian coun-
tries have the lowest prevalence of obesity in all age groups, except Finland which reported 
the prevalence of overweight and obesity in school children of 23.6 and 19.1% for boys and, 
respectively, girls [7, 11]. It is important to note that among preschool children, the highest 
prevalence rates of overweight and obesity were in Ireland (26 and 29% in boys and, respec-
tively, girls), United Kingdom (24.1 and 21.4% in boys and, respectively, girls). In school 
children, the prevalence of overweight and obesity has increased to 32.7% and, respectively, 
29.2% in 2007 the United Kingdom [7]. In developed countries, an increasing number of stud-
ies suggest that children of lower-income families are vulnerable to becoming obese, possibly 
due to poor dietary habits and limited opportunities for physical activity [7, 12]. In the UK, 
the prevalence of overweight and obesity in 11- to 12-year-old children was 25%, with higher 
rates in girls (29%) and students from lower socioeconomic backgrounds (31%), and the high-
est rates was observed in black girls (38%) [13].
Childhood Obesity
http://dx.doi.org/10.5772/65914
99
Data from Eastern European countries indicate the prevalence rate is smaller (15%), but ris-
ing. In Lithuania, the Russian Federation, Slovakia and Poland, the overweight and obesity 
prevalence ranges from 8.46 to 15.8% in children aged 6–12 years. It is likely that the huge 
economic burden and the associated poverty following the political transition in the 1990s 
may have contributed to the relatively low obesity prevalence in Eastern Europe [7].
3. The etiology of obesity and the risk factors
Obesity is a multifactorial disease with a complex etiology being involved genetic, environ-
mental, psycho-socio-cultural, neuroendocrine and metabolic factors, intestinal microbiota. 
The factors involved in its etiology included the ‘obesogenic’ environment, and the unhealthy 
dietary behaviors and patterns of physical activity [14].
There is growing interest in the role of experience in early life in the risk of becoming over-
weight or obese. In children, prenatal life may be a critical period when the long-term regula-
tion of energy balance is permanently ‘programmed’. The perinatal parameters and factors 
implicated in the etiology of obesity include maternal obesity, excessive weight gain in preg-
nancy, gestational diabetes, and maternal smoking, duration of breastfeeding, rapid infancy 
weight gain and other cultural or familial factors associated with childhood eating patterns 
and activity levels [14, 15].
Maternal obesity is a strong predictor of overweight and obesity in children. Obesity in preg-
nant women was found to be associated to high newborn weight and also causing obesity and 
metabolic syndrome risk in later life of the individual. Intrauterine growth restriction is asso-
ciated with the development of central adiposity and adult-onset cardiovascular risk [4, 14].
Child's exposure to passive smoking, since the product conception stage, predisposes to the 
development of obesity and obesity related diseases as a result [14, 16, 17].
Breastfeeding could help infants to better recognize satiety signals and hence to better self-
regulate energy intake. The prevalence and duration of breastfeeding is higher in countries 
with relatively lower prevalence of childhood obesity such as Sweden, Finland and Austria, in 
comparison to countries such as Italy, Greece and the UK, where is less [7, 14, 15].
Ethnicity is associated with differences in eating behaviors, preferences, and cultural influ-
ences may contribute to obesity among children and youth in minority populations.
The environmental factors are represented by: over-nutrition (high fat, high sugar diets), sed-
entary lifestyle, short sleep duration, abuse of drugs (antibiotics, corticosteroids, anti-epilep-
tics drugs), smoking and alcohol. Almost all obesity in children is strongly influenced by 
environmental factors, caused by a sedentary lifestyle or a caloric intake that is greater than 
needs. However, this explains only a part of obesity risk, but is important targets for treat-
ment such they can be modifiable.
Sugar-sweetened beverages—the literature evidence suggests that consumption of sugar-
sweetened beverages is an important factor in the development of obesity in some  individuals. 
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In the United States, sugar-sweetened beverages supplied an average of 270 kcal/day, repre-
senting 10–15% of total caloric intake. In a separate randomized trial on children aged 5–12 
(primarily normal weight), consuming one serving of a sugar-free beverage daily was asso-
ciated with less weight gain and fat accumulation than consuming one serving of a sugar-
sweetened beverage. Other studies have found that dietary salt intake is associated with 
increased intake of sugar-sweetened beverages, perhaps because of increased thirst [18, 19].
Television viewing is an environmental influence on the development of obesity in children. 
Contact of a child with television begins in the newborn stage and tends to increase continu-
ously. In the first year of life, children react to the screen characters with mimics and voice. 
Toddlers spend approximately 1 h a day watching television, and from the 4th year of life 
the exposure to other type of media expands and rises significantly to reach 7 out of 24 h 
per day. The presence of a television in a child's bedroom and any time spent in watching 
television are directly related to the prevalence of obesity in children and adolescents. A sig-
nificant association between advert exposure and childhood obesity has been demonstrated 
in a cross-cultural study which included data from the USA, Australia and eight European 
countries [18, 20–22].
Video games—the use of PC or console games has been associated with obesity in children. 
Half of American children have either a DVD, video or game console in their bedroom and, 
third, a computer with access to Internet [22, 23].
Sleep—there is a reported association between shortened sleep duration and obesity. A causal 
association arises from a short-term experimental study in which sleep deprivation for 1 week 
was associated with increased food intake, weight gain and higher leptin levels as compared 
to the child's usual sleep. Moreover, sleep may have an association with insulin resistance, 
independent of its association with obesity. The mechanism between sleep duration and obe-
sity has not been well-known, but may comprise dysfunction in serum leptin and/or ghrelin 
levels, both are involved in the regulation of appetite [4, 18]. A meta-analysis found that sleep 
is positively associated with fat mass in toddlers. A positive association between nighttime 
sleep and BMI z-scores were observed in the study reported by Kuzik and Carson [24].
Medications that may cause weight gain in children include cortisol and other glucocorti-
coids, sulfonylureas, tricyclic antidepressants (TCAs), monoamine oxidase inhibitors, such as 
phenelzine, oral contraceptives, insulin (in excessive doses), thiazolidinediones, risperidone, 
clozapine [25].
Other environmental factors that have been proposed as possible contributors to obesity 
include the influences of gut microbiota, toxins and viruses. Due to the influence of gut micro-
biota, it has been suggested that there exists a relationship between the resident intestinal 
bacteria and the potential for weight gain. Effect of microbiota may be partially responsible 
for increased rate of obesity in children born via cesarean section. Intestinal bacteria seem 
to influence several factors leading to development of obesity complications such us non-
alcoholic steatohepatitis, cardiovascular disease and insulin resistance in humans [26]. It has 
been suggested that obesity can be triggered or worsened by exposure to a virus. Adenovirus 
36 increases body fat in several animal models [18].
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Other epidemiologic studies highlight the possibility that obesity could be triggered or exac-
erbated by exposure to environmental endocrine disrupting chemicals (dichlorodiphenyltri-
chloroethane—DDT and bisphenol A—BPA). Some studies in adults and children establish 
an association between urinary BPA levels and obesity or obesity related diseases, as well as 
diabetes and cardiovascular disease [18].
Endocrine disruptors can disturb every level of the endocrine system. They can interrupt the 
action of enzymes involved in steroidogenesis. The endocrine disruptors inducing obesity 
are called obesogens and have been revealed to target transcription regulators that function 
to control intracellular lipid homeostasis as well as proliferation and differentiation of adi-
pocytes. The main group of regulators that are targeted represent a group of nuclear hor-
mone receptors recognized as peroxisome proliferator-activated receptors (PPARα, δ and γ). 
PPARγ is considered to be the master regulator of adipogenesis and plays key roles in nearly 
all aspects of adipocyte biology. Other endocrine disruptors are known to promote adipogen-
esis, but probably do not act through PPARγ, these include BPA, organophosphate pesticides 
and monosodium glutamate [27].
Hormonal disorders associated with childhood obesity include growth hormone deficiency, 
growth hormone resistance, hypothyroidism, leptin deficiency or resistance to leptin action, 
glucocorticoid excess (Cushing syndrome), precocious puberty, polycystic ovary syndrome 
(PCOS), prolactin-secreting tumors. Furthermore, in obese individuals, dysfunction in the 
gut-brain hypothalamic axis and ghrelin/leptin hormonal pathway has been proposed to have 
a role in excess energy intake and abnormal appetite control [28].
3.1. Genetic factors
Specific syndromes and single gene defects that are linked to obesity in children have been 
identified. These are very rarely causes of obesity, Generally, monogenic forms of childhood 
obesity are very rare, accounting for <1% in children. Mutations in only a few genes are known 
to cause the development of severe obesity in early childhood. Single gene disorders that can 
cause obesity include deficiency in leptin or its receptor, mutation in leptin gene, deficiency 
of proopiomelanocortin (POMC), haploinsufficiency receptor 4 and accessory protein recep-
tor 2 of melanocortin, also disorders of protein convertase 1 [4, 18]. The leptin/leptin receptor 
system regulate food intake through reduce feeding and increased energy expenditure. Some 
forms of monogenic obesity like congenital leptin deficiency benefits from leptin substitution 
therapy that leads to significant decrease in weight [29].
Moreover, children with genetic syndromes associated with obesity typically have early onset 
obesity and characteristic signs on physical examination, including dysmorphic features, 
developmental delay, short stature or intellectual disability, retinal changes or deafness. The 
Prader Willi syndrome is the most common among obesity syndromes and is characterized 
by hypotonia and feeding difficulties during infancy, hyperphagia and obesity developing 
during early childhood and developmental delay. Other syndromes associated with child-
hood obesity are Pseudohypoparathyroidism, Laurence Moon Biedl (Bardet Biedl) syndrome, 
Cohen syndrome, Down syndrome and Turner syndrome [30].
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4. Pathophysiology of comorbidities of pediatric obesity
Complications of pediatric obesity occur during childhood and adolescence and increased the 
risk for morbidity and mortality into adulthood.
Obesity, particularly abdominal, has been shown to be an important risk factor for a num-
ber of chronic diseases in adults. Associated with obesity in childhood is a wide range of 
health serious complications and increased risk of premature onset year of illnesses. The 
most important organic complications are dyslipidemia, arterial hypertension, type 2 dia-
betes mellitus, nonalcoholic fatty liver disease, polycystic ovaries syndrome, orthopedic and 
respiratory complications. The metabolic syndrome (central obesity, hypertension, glucose 
intolerance and hyperlipidemia) increases risk for cardiovascular morbidity and mortality. 
The most frequent psychological complications are disorders concerning body image, eating 
habits and depression [4, 19].
Insulin resistance is defined as a decreased response of tissue to the action of insulin, and due 
to lowering of the capacity of insulin to stimulate glucose utilization by muscle cells and fat 
cells and to suppress hepatic glucose production, and insulin resistance in the protein and 
lipid metabolism. The association of obesity with insulin resistance is well-known: the factors 
and the mechanism by which the insulin resistance compensation is produced by beta islet 
cells and those that lead to the "failure" of the pancreatic beta cells in obese patients. It seems 
that microvascular changes associated with diabetes begin early stages still hyperinsulinemia 
with normal glycaemia or impaired oral glucose tolerance test. A central role in regulating 
central nervous system appears to have fat in the body's glucose metabolism by integrating 
information neural hormonal and nutritional. Insulin via the insulin receptor in the central 
nervous system regulates food intake and energy homeostasis. Adipose tissue seems to play 
a role in insulin resistance by metabolites, hormones and adipocytokines influencing differ-
ent stages of insulin action. Fat distribution is an important determinant of insulin resistance, 
abdominal fat tissue lipolysis is easier and is less sensitive to insulin anti-lipolysis than sub-
cutaneous adipose tissue. Total fat in children correlates well with the visceral and the rela-
tionship of visceral adipose tissue and the cardiovascular risk factors demonstrated in adults 
appears to differ [4, 31].
4.1. Dyslipidemia
Research on elucidating the relationship between obesity and atherogenic dyslipidemia 
appears to show a close relationship with insulin resistance. Three major events are based 
on atherogenic dyslipidemia of obesity with insulin resistance: excessive production of very 
low density lipoprotein-cholesterol, lipoprotein catabolism and defective catabolism of high 
density lipoprotein-cholesterol. Visceral fat is associated with impaired insulin-glucose 
homeostasis, the plasma lipoprotein, in particular increased triglycerides and decreased high 
density lipoprotein-cholesterol [4].
Arterial hypertension is recognized as an important component of metabolic syndrome in 
adults, but in children, its role is not very clear. While some studies hypertension is  considered 
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the direct effect of obesity, insulin resistance in others, it is considered a predictor of 
 hypertension, independent of BMI. Arterial hypertension in the pathogenesis of obesity and 
insulin resistance may play a role in which leptin resistance physiological actions of insulin 
that leptin central nervous system vessels and kidneys should be changed. Studies suggest 
the involvement of oxidative stress in the pathogenesis and hypertension by stimulating reac-
tive oxygen species by the renin–angiotensin–aldosterone system [32].
5. Clinical assessment of obesity
Obesity is more complicated to diagnose in children than in adults because children increase 
in height, weight and body fat naturally as they grow. The criteria for defining obesity in 
children are the fat mass assessment, the distribution of the body fat measure by age and sex 
and a centile cut off to define the point in the body fat measure distribution corresponding to 
obesity [33].
Initial assessments of these patients should include taking a careful history (investigating 
comorbidities, family history and potentially modifiable behaviors) and physical examination 
with BMI plotted on a BMI-for-age chart.
The careful history includes as follows: elements of perinatal life (gestational diabetes, mater-
nal obesity, birth weight, infant feeding, medications—glucocorticoids, some antiepileptics, 
antipsychotics), weight history (onset of parental and child obesity, current eating behaviors, 
management interventions), complications (psychological, sleeping disorders, gastrointesti-
nal and orthopedic complications, menstrual disturbances in girls), family history (ethnicity, 
history of obesity, type 2 diabetes, cardiovascular disease, dyslipidemia, obstructive sleep 
apnea, polycystic ovary syndrome, bariatric, surgery, eating disorders) and lifestyle history 
(detailed exploration of family eating, nutritional, and activity patterns, sleep) [34].
Physical examination should include the following: anthropometric data (weight, height, BMI, 
abdominal circumference), adiposity distribution (central versus generalized), assess blood 
pressure, markers of comorbidities and physical stigmata of a genetic syndrome, endocrine 
disorders, congenital or acquired hypothalamic alterations (fewer than 5% of cases) [4, 34].
The child’s BMI must be plotted on nationally recommended BMI—for age charts. Children 
and adolescents with a BMI ≥99th percentile are even more likely to have comorbidities [4].
Abdominal circumference (AC) is also used for assessing excess fatty tissue is an indirect 
method for assessing abdominal fat tissue. Given the strong association between body fat 
distribution and risk of metabolic complications, it is helpful to calculate in all children with 
excess weight from the age of 5 years and upwards the relationship between waist circumfer-
ence and height.
Other methods of measuring fat, such as bioelectrical impedance, and total body water mea-
surement are used in research, but not in clinical evaluation [4].
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Careful screening for hypertension using an appropriately sized blood pressure cuff is impor-
tant (e.g., hypertension is diagnosed if systolic or diastolic blood pressure falls over 95th per-
centile for age, gender and height in at least three occasions) [35, 36].
Endocrine problems must be considered carefully on signs suggesting hypothyroidism 
 (goiter), insulin resistance (acanthosis nigricans), polycystic ovary syndrome (hirsutism, 
excessive acne) and Cushing syndrome (violaceous striae, moon face) [36].
Symptoms of polyuria, nocturia or polydipsia may be the result of type 2 diabetes melli-
tus. Depending on their durations, overweight and obesity are important potential risk fac-
tors for respiratory complications (asthma, sleep apnea), abdominal pain or hepatomegaly 
(gastroesophagial reflux, nonalcoholic fatty liver), musculoskeletal problems (hip or knee 
pain, genu valgum, slipped capital femoral epiphysis, Blount disease) and psychological dis-
orders (depression, body dissatisfaction, bulimia nervosa impaired social relationships and 
decreased health-related quality of life depression) [4, 37–39].
Reproductive system and Tanner stage disturbance can reveal premature puberty, apparent 
micropenis (but normal penis may be hidden in fat), undescended testis/micropenis (Prader 
Willi syndrome) and must be evaluated [4].
The degree of investigation is dependent on the patient's age and severity of obesity, the find-
ings on history and physical examination, and associated familial risk factors.
First-line investigations recommended in cases of childhood obesity include fasting plasma 
glucose, triglycerides, low-density lipoprotein and high-density lipoprotein cholesterol, liver 
function tests and, possibly, insulinemia [4, 34, 35].
The investigations for overweight children include the fasting lipid screening test. If this chil-
dren present risk factors represented by hypertension, dyslipidemia and family history of 
diabetes, it is necessary to evaluated the serum levels of fasting glucose, alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST) to every 2 years (increased value of ALT 
and AST is associated with possible non-alcoholic fatty liver disease) [36].
In obese, children is necessary to evaluated serum levels of fasting lipids, glucose, ALT and 
AST every 2 years, and insulinemia [4, 34, 35].
Second-line investigations may include liver ultrasound, an oral glucose tolerance test, more 
detailed endocrine assessment and polysomnography [4, 34].
Patients with fasting blood glucose >100 mg/dL or overweight children (BMI 85th to 95th 
percentile) who have a family history of diabetes mellitus or signs of insulin resistance 
(acanthosis nigricans), polycystic ovary syndrome, or metabolic syndrome should also be 
evaluated with an oral glucose tolerance test [4, 34, 35]. If the result of oral glucose tolerance 
test is more than 126 mg/dL, counseling and repeating test is necessary because pediatric 
obesity can lead to impaired glucose tolerance. The value of HbA1c of 40 mmol/mol (5.8%) 
is an appropriate screening tool for diagnosing impaired glucose tolerance [40, 41].
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Liver ultrasound is recommended for all obese children and adolescents. In children with 
confirmed ALT >40 IU/L or palpable liver, more thorough diagnostic tests are advisable with 
gamma-GT and differential diagnosis of hepatitis [41].
Other laboratory tests such as thyroid function tests (if there is a faster increase in weight 
than height), pelvic ultrasound and hormonal doses in cases of suspected polycystic ovary 
syndrome have been recommended [4, 41].
Psychological and psychiatric evaluations are essential to identify psychological disturbances 
including depression, loss-of-control eating, unhealthy and extreme weight control behav-
iors, and decreased health-related quality of life which are warning signs of bulimia nervosa 
and binge-eating disorder [39].
In patients with hypertension more diagnostic tests should be done: cardiac exam: ECG and 
echocardiogram, standard urinalysis, microalbuminuria, creatinine and potassium levels 
[4, 41].
We should realize screening for diagnosis of metabolic syndrome in the presence of at least 
three of the following situations: BMI indicate obesity or waist circumference/height ratio >0.5, 
systolic and/or diastolic blood pressure >95th percentile, fasting blood glucose >100 mg/dL, 
serum level of triglycerides >95th percentile, serum level of HDL cholesterol [4, 41].
According to International Diabetes Federation (IDF), the consensus definition of metabolic 
syndrome in children (older than 6 years) and adolescents are as follows:
- for children aged 6–10 years:
- obesity mean a waist circumference >90th percentile
- in case of metabolic syndrome that cannot be diagnosed, the measurements should be made 
if there is a family history of metabolic syndrome, type 2 diabetes mellitus, dyslipidemia, 
cardiovascular disease, hypertension or obesity.
- IDF suggests for weight reduction to use an appropriate message in patients with abdominal 
obesity.
- for children aged 10–16 years:
- obesity mean a waist circumference >90th percentile (or adult cut-off if lower).
- serum triglycerides level >1.7 mmol/l
- serum HDL cholesterol level <1.03 mmol/l
- systolic blood pressure >130 mmHg or diastolic blood pressure >85 mmHg
- blood glucose >5.6 mmol/l (oral glucose tolerance test recommended) or medical history of 
type 2 diabetes mellitus
- for children >16 years:
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- should use the IDF criteria for adults. According to the recent IDF definition, a person with 
metabolic syndrome must have central obesity (defined as waist circumference using ethnic-
ity-specific values) and any two of the following four factors:
- serum triglyceride levels >150 mg/dl (1.7 mmol/l) or specific treatment recommended for 
this abnormality
- reduced serum HDL cholesterol level <40 mg/dl (1.03 mmol/l) in males and <50 mg/dl 
(1.29 mmol/l) in females, or specific treatment for this lipid abnormality
- raised blood pressure: systolic blood pressure >130 mmHg or diastolic blood pressure of 
85 mmHg or treatment for previously diagnosed hypertension
- raised fasting plasma glucose >100 mg/dl (5.6 mmol/l) or previously diagnosed type 2 dia-
betes (if above 5.6 mmol/l or 100 mg/dl, the oral glucose tolerance test is strongly recom-
mended but is not necessary to define the presence of this syndrome) [32, 42].
Vitamin D deficiency is common in obese children and is associated with risk factors for 
type 2 diabetes in obese children, but they are not still recommended by national clinical 
practice guidelines as routine measures [43].
6. Management of child obesity
Prevention is the best cost/benefit approach for the management of obesity in children and, in 
the future, of adulthood. Childhood obesity is a multifaceted problem embedded in physiolog-
ical, behavioral, genetic, socioeconomic, environmental and political contexts, and the actions 
to prevent childhood obesity must therefore be taken in multiple settings. Public awareness 
campaigns, social marketing and behavior-change communication related to nutrition and 
physical activity implemented in countries together are very important strategies regard-
ing childhood obesity prevention. The critical periods of pediatric obesity characterized by 
important changes in adiposity growth velocity or obesity related behavior are represented 
by the first year of life, the preschool (“adiposity rebound”) and adolescence years. The transi-
tion period from childhood to adolescence is characterized by important behavioral changes 
and decreased physical activity [44]. The obesity primary prevention begins in pregnancy 
period (healthy food diet), continuing with promoting the breastfeeding in the first 2 years of 
life, and then with support for healthy eating habits (low sugar consumption, eat breakfast 
every day, eat at home with family, avoid fast—food meals, avoid television in the first years 
of life and limit television to less than 2 h per day after then, etc. [4, 41, 45, 46].
Management of obesity should be based on risk factors, including age, severity of overweight 
and obesity and comorbidities, as well as family history and support. Management interven-
tion strategies are available and include nutrition, physical activity, behavior and lifestyle 
changes, medication and surgical considerations. Treatment largely focuses on sustained life-
style changes with family involvement. There are several broad principles of conventional 
management: management of comorbidities, family involvement, taking a developmentally 
Childhood Obesity
http://dx.doi.org/10.5772/65914
107
appropriate approach, the use of a range of behavior change techniques, long-term dietary 
change, increased physical activity and decreased sedentary behaviors. The primary goal 
for all children with uncomplicated obesity is the long-term improvement of physical health 
through healthy lifestyles. In obese children with a secondary complication, specific treat-
ment of the complication is an important goal. Effective weight reduction is one of the key ele-
ments in the treatment of comorbidities. In morbid obesity, bariatric surgery and laparoscopic 
sleeve gastrectomy have been used in adolescence [4, 34, 41].
In order to plan a developmentally appropriate approach, it is essential to consider the 
developmental age of the patient and the resultant level of parental engagement that will 
be required. Most successful interventions have been family based and take into account the 
child’s developmental age. In preadolescent children, a parent-based program, without direct 
engagement of the child, might be more appropriate than a child centered approach.
Depending on the age of the child, the present of parents must be or not compulsory. For 
example, if we talk about adolescents, the present of parents in not recommended. However, 
the parents must participate at counseling session that are designed for them.
Because obesity is multifactorial, not all children and adolescents will respond to the same 
approach. Behavior therapy, healthy diet and increasing physical activity are the great sec-
tions of obesity treatment. Referral to multidisciplinary, comprehensive pediatric weight—
management programs is ideal for obese children whenever possible [4, 34].
Behavior modification strategy has a large effect on weight reduction. The set of techniques 
employed to change thought processes and actions associated with eating, physical activity 
and sedentary are components of behavior strategies. For the obese adolescent, there are sev-
eral ways to help him acquiring a healthy lifestyle: to log daily his physical effort and food 
intake; to participate to motivational interview; to receive permanent psychological support 
for positive lifestyle changes [34, 41, 46].
Dietary interventions are usually part of a broader lifestyle change program can be effective 
in achieving relative weight loss in children and adolescents. Dietary interventions should 
follow national nutrition guidelines which have an emphasis on:
- at least five meals over the day (three meals + two snacks)
- restrict/replace specific high calorie foods with others less rich in calories
- the protein content: it is suggested the 14 meals per week: meat, three to four times a week; 
fish, three to four times a week; legumes, three to four times a week; cheese and eggs, once a 
week.
- carbohydrates should account for at least 50% of total calories, preferring low glycemic 
index foods: cereals such as pasta, barley and whole wheat products—twice a day; legumes; 
fruit and vegetables (not canned or pureed) five servings a day) and by limiting foods that 
combine a high glycemic index to a high glycemic load (bread, rice, potatoes, sweets, sugar, 
fruit juices, sweet drinks).
- the total fat in the diet should account for no more than 30% of total calories.
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- the adequate intake of fiber in grams/day: five servings a day of fruits and vegetables in sea-
son, not canned or pureed, and legumes four times a week are recommended.
- decreased portion sizes.
- drinking water as the main beverage and reduction in sugary drink intake.
- involvement of the entire family in making sustainable dietary changes [34, 41].
Increasing physical activity can decrease risk for cardiovascular disease, improve well-being 
and contribute to weight loss:
- walking or cycling for transport,
- undertaking household chores and playing,
- organized exercise programs,
- limiting television and other small screen recreation to less than 2 h per day is particularly 
strategic, but may be challenging,
- is recommended at least 60 min of moderate exercise.
Parental involvement is vital and may include monitoring and limiting television use, role 
modeling of healthy behaviors and providing access to recreation areas or recreational 
equipment.
Existing recommendations on management of pediatric obesity suggest that drug therapy can 
be used in the treatment of severely obese adolescents. Orlistat can be useful as an adjunct to 
lifestyle changes in severely obese adolescents and metformin can be used in older children 
and adolescents with clinical insulin resistance [4, 34, 41].
Bariatric surgery should be considered in adolescents with complete or near-complete skel-
etal maturity, who are severely obese with a body mass index of more than 40 kg/m2 or weight 
exceeding 100% of ideal body, and a medical complication resulting from obesity, after they 
have failed 6 months of a multidisciplinary weight management program. Preoperative care 
and counselling is very important if we want to have good long-term results for bariatric 
surgery patients. This care must be provided by specialist in various medical fields: endocri-
nology, gastroenterology, cardiovascular, pneumology, etc. All this effort must by sustained 
with nutritional and psychological support [4, 34, 41,47, 48].
Childhood obesity treatment is based on sustained lifestyle changes with family involvement. 
Behavior therapy, healthy diet and increasing physical activity are the great sections of obe-
sity treatment.
7. Conclusions
Childhood and adolescent obesity is a major health problem. The prevalence of childhood 
obesity in Europe is ten times higher than it was in the 1970s. The increasing occurrence in 
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children of disorders, such as type 2 diabetes, is a consequence of this obesity epidemic. Initial 
assessments of these patients should include taking a careful history (investigating comor-
bidities, family history and potentially modifiable behaviors) and physical examination. 
The degree of investigation is dependent on the patient's age and severity of obesity, the find-
ings on history and physical examination, and associated familial risk factors. The increased 
prevalence of obesity in childhood and adolescence highlights the need for effective treatment 
approaches. There are several broad principles of conventional management: management of 
comorbidities, family involvement, the use of a range of behavior change techniques, long-
term dietary change, increased physical activity and decreased sedentary behaviors. Pediatric 
patients and their families should be counselled on nutritional interventions including limit-
ing sugar-sweetened beverages, eating nutrient-dense breakfasts, limiting eating out at fast 
food restaurants, families eating together, increased exercise and decreased time in front of 
computer and TV screens. For adolescents with severe obesity, lifestyle changes are manda-
tory. This change must be supported with medical therapy (the only drugs approved by the 
health organizations are Orlistat and Metformin; these treatments do not exclude metabolic 
surgery). Finally, given the high prevalence and chronic nature of obesity, coordinated mod-
els of care for health service delivery for the management of pediatric obesity are needed.
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